1. Home
  2. ATLC vs CTKB Comparison

ATLC vs CTKB Comparison

Compare ATLC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLC
  • CTKB
  • Stock Information
  • Founded
  • ATLC 1996
  • CTKB 1990
  • Country
  • ATLC United States
  • CTKB United States
  • Employees
  • ATLC N/A
  • CTKB N/A
  • Industry
  • ATLC Finance: Consumer Services
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ATLC Finance
  • CTKB Health Care
  • Exchange
  • ATLC Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • ATLC 732.1M
  • CTKB 718.8M
  • IPO Year
  • ATLC 1999
  • CTKB 2021
  • Fundamental
  • Price
  • ATLC $49.05
  • CTKB $2.77
  • Analyst Decision
  • ATLC Strong Buy
  • CTKB Hold
  • Analyst Count
  • ATLC 5
  • CTKB 4
  • Target Price
  • ATLC $62.00
  • CTKB $6.00
  • AVG Volume (30 Days)
  • ATLC 47.2K
  • CTKB 1.1M
  • Earning Date
  • ATLC 05-08-2025
  • CTKB 05-08-2025
  • Dividend Yield
  • ATLC N/A
  • CTKB N/A
  • EPS Growth
  • ATLC 21.75
  • CTKB N/A
  • EPS
  • ATLC 5.17
  • CTKB N/A
  • Revenue
  • ATLC $424,877,000.00
  • CTKB $197,050,000.00
  • Revenue This Year
  • ATLC $270.55
  • CTKB $3.25
  • Revenue Next Year
  • ATLC $11.94
  • CTKB $8.58
  • P/E Ratio
  • ATLC $9.48
  • CTKB N/A
  • Revenue Growth
  • ATLC 17.71
  • CTKB N/A
  • 52 Week Low
  • ATLC $25.14
  • CTKB $2.37
  • 52 Week High
  • ATLC $64.70
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • ATLC 41.02
  • CTKB 40.75
  • Support Level
  • ATLC $48.36
  • CTKB $2.37
  • Resistance Level
  • ATLC $49.80
  • CTKB $2.61
  • Average True Range (ATR)
  • ATLC 1.90
  • CTKB 0.18
  • MACD
  • ATLC -0.55
  • CTKB 0.01
  • Stochastic Oscillator
  • ATLC 23.48
  • CTKB 50.63

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: